Medical applications of hyperthermia based on magnetic nanoparticles

Recent Patents on Biomedical Engineering

Volumn 2, Issue 2, 2009, Pages 110-120

  Boehm, Frank J ^a   Chen, Aicheng ^b  

^a NanoApps Medical Inc   (Canada)

^b LAKEHEAD UNIVERSITY   (Canada)

Author keywords

Cancer cells; Drug delivery; Ferrofluids; Hyperthermia; Magnetic nanoparticles (mnps); Superparamagnetic iron oxide nanoparticles (spions); Surfactant; Targeting; Tissue ablation; Tissue fusion; Tumors

Indexed keywords

CANCER CELLS; FERRO FLUID; MAGNETIC NANOPARTICLES; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLES; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLES (SPIONS); SURFACTANT; TISSUE ABLATIONS;

ABLATION; CELLS; DRUG DELIVERY; HISTOLOGY; IRON OXIDES; LASER TISSUE INTERACTION; MAGNETIC FLUIDS; MEDICAL APPLICATIONS; MICROORGANISMS; NANOPARTICLES; NANOSTRUCTURED MATERIALS; SUPERPARAMAGNETISM; SURFACE ACTIVE AGENTS; TUMORS;

NANOMAGNETICS;

EID: 77951647838     PISSN: 18747647     EISSN: None     Source Type: Journal    
DOI: 10.2174/1874764710902020110     Document Type: Review

References (70)

1. Du Bois EF. The many different temperatures of the human body and its parts. West J Surg 1951; 59: 476-490.
2. Freitas Jr. RA. Nanomedicine, volume I: Basic Capabilities, Landes Bioscience. Georgetown: TX 1999; Vol. 1.
3. Nybo L, Secher NH, Nielsen B. Inadequate heat release from the human brain during prolonged exercise with hyperthermia. J Physiol 2004; 545 (2): 697-704.
4. McGahan JP, Browning PD, Brock JM, et al. Hepatic ablation using radiofrequency electrocautery. Invest Radiol 1990; 25: 267-270.
5. Lounsberry W, Goldschmidt V, Linke C. The early histologic changes following electrocoagulation. Gastrointest Endosc 1995; 41: 68-70.
6. Zhu, H.: EP1952825 (2006).
7. Bruce, G., Jones, N., Stephen, K.: WO97043005 (1997).
8. Katschinskil DM, Robins HI, Schad M, Frede S, Fandrey J. Role of tumor necrosis factor in hyperthermia-induced apoptosis of human leukemia cells. Cancer Res 1999; 59: 3404-3410.
9. Jin, S., Pisanic, T.: WO2005065282 (2005).
10. Sun YM, Fu J, Zhang W, Zheng ZX, Huang CZ, Yuan XH. Effects of hyperthermic chemotherapy on gastrointestinal cancer cells in vitro. Ai Zheng 2006; 25(8): 974-978.
11. Overgaard J, Overgaard M. Is there a role for hyperthermia in gastrointestinal tract cancer? Recent Results Cancer Res 1988; 110: 244-253.
12. Curley SA, Cherukuri PP, Briggs KK, et al. Noninvasive radiofrequency field-induced hyperthermic cytotoxicity in human cancer cells using cetuximab-targeted gold nanoparticles. J Exp Ther Oncol 2008; 7(4): 313-326.
13. Gannon CJ, Patra CR, Bhattacharya R, Mukherjee P, Curley SA. Intracellular gold nanoparticles enhance non-invasive radiofrequency thermal destruction of human gastrointestinal cancer cells. J Nanobiotechnol 2008; 6: 2.
14. Cho HK, Lush RM, Bartlett DL, Alexander HR, Wu PC, Libutti SK. Pharmacokinetics of cisplatin administered by continuous hyperthermic peritoneal perfusion (CHPP) to patients with peritoneal carcinomatosis. J Clin Pharmacol 1999; 39(4): 394-401.
15. Park BJ, Alexander HR, Libutti SK, Wu P, Royalty D, Kranda KC. Treatment of primary peritoneal mesothelioma by continuous hyperthermic peritoneal perfusion (CHPP). Ann Surg Oncol 1999; 6(6): 582-590.
16. Liberale G, Pocard M, Manganas D, Ducreux M, Lasser P, Elias D. Hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis of digestive and peritoneal origin: Rationale. Acta Chir Belg 2006; 106: 291-296.
17. Curley SA. Radiofrequency ablation of malignant liver tumors. Oncologist 2001; 6(1): 14-23.
18. Corry PM, Barlogie B, Tilchen EJ, Armour EP. Ultrasound-induced hyperthermia for the treatment of human superficial tumors. Int J Radiat Oncol Biol Phys 1982; 8(7): 1225-1229.
19. Liu Y, Cho CW, Yan X, et al. Ultrasound induced hyperthermia increases cellular uptake and cytotoxicity of P-glycoprotein substrates in multi-drug resistant cells. Pharm Res 2001; 18(9): 1255-1261.
20. Kislev, H.: US20080045865 (2008).
21. Kang, K.A., Shi, D.: WO2006102307 (2006).
22. Rüfenacht, D., Doelker, E., Jordan, O., Chastellain, M., Petri-fink, A., Hofmann, H.: WO2006125452 (2006).
23. Xiang, X.D., Yang, H.: WO2006116403 (2006).
24. Xu, Z., Gu, Y.: WO03005029 (2003).
25. Zeng, Q., Baker, I.: WO2008140831 (2008).
26. Jordan A, Wust P, Scholz R, et al. Cellular uptake of magnetic fluid particles and their effects on human adenocarcinoma cells exposed to AC magnetic fields in vitro. Int J Hyperthermia 1996; 12(6): 705-722.
27. Jordan A, Scholz R, Wust P, et al. Endocytosis of dextran and silan-coated magnetite nanoparticles and the effect of intracellular hyperthermia on human mammary carcinoma cells in vitro. J Magn Magn Mater 1999; 194: 185-196.
28. Penades, S., Martin-Lomas, M., De La Fuente, J.M., Rademacher, T. W.: WO2004108165 (2004).
29. Haik, Y., Chen, C.J.: US20050249817 (2005).
30. Baldi, G., Bonacchi, D., Innocenti, F., Lorenzi, G., Bitossi, M., Ferruti, P., Ranucci, E., Ricci A., Comes, F. M.: WO2008074804 (2008).
31. Granov, A.M., Derkach, V.Y., Granov, D.A.: US5236410 (1991).
32. Xiao, J.Q., Zhao, Y.: US20070277649 (2007).
33. Gangopadhyay AK, Balachandrànb U, Poeppelb RB. Flux pinning and irreversibility temperature in melt-grown, quench-melt-grown, and sintered YBa2Cu3O6+y superconductors. Physica C 1992; 201: 6-12.
34. Baldi, G., Ricci, A., Comes, F.M., Bonacchi, D., Bitossi, M.: WO2007077240 (2007).
35. Jordan A, Scholz R, Wust P, Fahling H, Felix R. Magnetic fluid hyperthermia (MFH): Cancer treatment with AC magnetic field induced excitation of biocompatible superparamagnetic nanoparticles. J Magn Magn Mater 1999; 201: 413-419.
36. Chung, B.H., Lim, Y.T., Kim, J.K.: WO2008018707 (2008).
37. Hyeon, T., Kim, J.Y., Cho, M., Kim, S.K., Lee, J.: WO2008048074 (2008).
38. Giri JA, Ray A, Dasgupta S, Datta D, Bahadur D. Investigation on Tc tuned nano particles of magnetic oxides for hyperthermia applications. Bio Med Mater Eng 2003; 13: 387-399.
39. Douglas, T., Suci, P., Young, M.: WO2008048288 (2008).
40. Shinkai M. Functional magnetic particles for medical application. Biosci Bioeng 2002; 94: 606-613.
41. Gilchrist RK, Medal R, Shorey WD, Hanselman RC, Parrott JC, Taylor B. Selective inductive heating of lymph nodes. Ann Surgery 1957; 146(4): 596-606.
42. Ivkov R, DeNardo SJ, Daum W, et al. Application of high amplitude alternatingmagnetic fields for heat induction of nanoparticles localized in cancer. Clin Cancer Res 2005; 11(19): 7093s-7103s.
43. Andra In: Magnetism in Medicine: A Handbook, Andra and Nowak ed., WileyVCH Berlin 1998; 455.
44. Leuschner C, Kumar C, Hansell W, Soboyejo W, Zhou J, Hormes J. LHRHconjugated magnetic iron oxide nanoparticles for detection of breast cancer metastases. Breast Cancer Res Treatment 2006; 99(2): 163-176.
45. Kanzius, J., Steinbrink, W. H., Mcdonald, R. J., Keating M. J.: WO2005118065 (2005).
46. Wang, X., Greenwald, H., Weiner, M.L.: WO2006083796 (2006).
47. Rovers SA, Hoogenboom R, Kemmere MF, Keurentjes JTF. Relaxation processes of superparamagnetic iron oxide nano-particles in liquid and incorporated in poly(methyl methacrylate). J Phys Chem C 2008; 112(40): 15643-15646.
48. Zahn, M., Adalsteinsson, E.: WO2007035871 (2007).
49. Chenite, A., Chaput, C., Combes, C., Selmani, A., Jalal, F., US6344488 (1999).
50. Berger, J., Gurny, R., Reist, O.M.: WO2005097871 (2005).
51. Jackson, J., Zhang, X., Burt, H.M.: WO99021908 (1999).
52. Castella, P., Kim, J.: US20080095714 (2008).
53. Raju, B., Savery, D.: WO2007015179 (2007).
54. Josephson L, Lewis J, Jacobs P, Hahn PF, Stark DD. The effects of iron oxides on proton relaxivity. Mag Reson Imag 1988; 6(6): 647-653.
55. Bhatia, S.N., Harris, T., Agarwal, A., Min, D., Derfus, A.M., Von Maltzahn, G.: WO2008073856 (2008).
56. Rabin Y. Is intracellular hyperthermia superior to extracellular hyperthermia in the thermal sense? Int J Hyperthermia 2002; 18(3): 194-202.
57. Wilk, P.J., Essig, M.N.: US6231496 (1999).
58. Chang, W.H., Chao-hung, K., Lin, C., Wang, S.: US20070154397 (2007).
59. Hanahan D, Bergers G, Bergsland E. Less is more, regularly: Metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice. J Clin Invest 2000; 105(8): 1045-1047.
60. Ansari A, Kuznetsov SV, Shen Y. Configurational diffusion down a folding funnel describes the dynamics of DNA hairpins. Proc Natl Acad Sci USA 2001; 98(14): 7771-7776.
61. Sengupta S, Eavarone D, Capila I, Zhao G, Watson N, Kiziltepe T. Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system. Nature 2005; 436: 568-572.
62. Constantinescu MA, Alfieri A, Mihalache G, et al. Effect of laser soldering irradiation on covalent bonds of pure collagen. Lasers Med Sci 2007; 22(1): 10-14.
63. McNally KM, Sorg BS, Chan EK, Welch AJ, Dawes JM, Owen ER. Optimal parameters for laser tissue soldering. Part I: Tensile strength and scanning electron microscopy analysis. Lasers Surg Med 1999; 24(5): 319-331.
64. Lauto A, Foster LJ, Ferris L, Avolio A, Zwaneveld N, Poole-Warren LA. Albumingenipin solder for laser tissue repair. Lasers Surg Med 2004; 35(2): 140-145.
65. Pohl D, Bass LS, Stewart R, Chiu DT. Effect of optical temperature feedback control on patency in laser-soldered microvascular anastomosis. J Reconstr Microsurg 1998; 14(1): 23-29; discussion, 9-30.
66. Brownlee, A.G., Elvin, C.M.: WO2007092998 (2007).
67. Bregy A, Kohler A, Steitz B, et al. Electromagnetic tissue fusion using superparamagnetic iron oxide nanoparticles: First experience with rabbit aorta. Open Surg J 2008; 2: 3-9.
68. Kroez M, Lang W, Dickneite G. Wound healing and degradation of the fibrin sealant Beriplast P following partial liver resection in rabbits. Wound Repair Regen 2005; 13(3): 318-323.
69. Hergt R, Andra W, d'Ambly C, et al. Physical limits of hypothermia using magnetic fine particles. IEEE Trans Magn 1998; 34(5): 3745.
70. Neuberger T, Schopf B, Hofmann H, Hofmann M, von Rechenberg B. Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system. J Magn Magn Mater 2005; 293(1): 483-496.